Skip to main content

Pharmaceutical Health Outcomes and Policy

  • multiple phop students
  • student researcher
  • faculty researcher

Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences

Application Deadline for Fall 2023: January 3, 2023

Apply now!


Download/View Program Flier PDF

The Pharmaceutical Health Outcomes and Policy (PHOP) Concentration within the Ph.D. in Pharmaceutical Sciences offers a learning and research environment that combines the collaborative opportunities of the Texas Medical Center’s world-class healthcare and scientific community with the academic resources and award-winning faculty at Houston’s only Carnegie Institute-designated Tier One public research university.

Pharmaceutical Health Outcomes and Policy consists of pharmaceutical practice and policy research, a multidisciplinary field that examines cost, access, and quality of pharmaceutical care from clinical, sociobehavioral, economic, organizational and technological perspectives.

Traditional and innovative areas of pharmaceutical health outcomes research include pharmacoepidemiology, pharmacoeconomics, comparative effectiveness research, patient-centered outcomes research, and translational research.

Program Eligibility

Completion of the PHOP Concentration of the Ph.D. program requires a minimum of 75 credit hours and successful defense of a doctoral dissertation. Applicants with a pharmacy background and/or advanced training will be given preference, and prospective students with health care-related backgrounds and/or experience are encouraged to apply.


The graduate program offers structured learning and experiences in health care systems, health care quality, health behavior, biostatistics, multivariate analyses, research methods and design, pharmacoepidemiology, and pharmacoeconomics.

Elective courses such as secondary data analyses, multilevel modeling, patient-reported outcomes, and risk adjustments provide advanced learning experiences, along with the opportunities to participate in grant proposal writing and teaching and research practicums.

Graduate courses in healthcare administration and healthcare evaluation and policy also are available from TMC academic institutions, such as The University of Texas School of Public Health and the University of Houston Clear Lake, to provide well-rounded graduate training in pharmaceutical health outcomes and policy.


The PHOP Department's faculty members come from a range of backgrounds, including pharmacoepidemiology, practice-based research, public health, biostatistics, and socio-behavioral and administrative pharmacy.

Among our faculty are recipients of awards and/or research grants from such organizations as the National Institutes of Health (NIH), the Agency for Healthcare Research & Quality (AHRQ), the Substance Abuse and Mental Health Services Administration (SAMHSA)/Texas Health and Human Services Commission, and pharmaceutical companies.

Program Dynamics

  • Yearly enrollment on a competitive basis
  • Financial assistance for qualified applicants based on availability
  • Collaboration with health care institutions in the Texas Medical Center and beyond
  • Collaboration with the pharmaceutical industry and pharmacy organizations

Financial Aid

Almost all of our students (international and domestic) are awarded stipends from Research or Teaching Assistantships, and are reimbursed for all tuition and fees. Please see the Financial Aid section for more details.

Job Opportunities

Pharmaceutical Health Outcomes and Policy Concentration graduates are in high demand by the pharmaceutical industry, healthcare consulting groups, pharmacy benefit management companies, healthcare organizations, academia and government/regulatory agencies.

Application and Admissions

For program admissions information, visit the PhD Graduate Admissions page here.

Recent PHOP News

2022 Headlines

Aparasu to Receive 2022 Paul Dawson Award from American Association of Colleges of Pharmacy

PhD Candidate Wins AMCP Poster Award for Study on Pharmacist Interventions Improving Hypertension, Diabetes Medication Adherence

Study Identifies Disparities in Diabetic Eye Care Among Minorities

Assistant Professor Appointed to State Council to Help Distribute Opioid Lawsuit Settlement Funds

PHOP Team Identifies Increased Risk of Overactive Bladder, Polypharmacy with Dementia Drug

2021 Headlines

Aparasu's Work to Assess Multiple Sclerosis Patient Medication Adherence, Relapse Rates Receives AHRQ Support

PHOP Student Earns 2nd AMCP Nexus Bronze with Anti-hypertensive Medication Adherence Research

UHCOP, UTHealth at Houston to Host NIH-funded Geriatrics Medication Safety Symposium 

12 Students Complete Cougar Health Research Academy in Public Health

New Alumnus Tyler Varisco Joins Health Outcomes and Policy Faculty

Aparasu Appointed as Inaugural Lokhandwala Professor for PHOP Chair

Record 7 PHOP Students Secure Research Internships in Pharmaceutical Industry

UHCOP, Houston Health Department Partner to Train Undergraduate Student for Public Health Work

ISPOR 2021 Virtual Student-Faculty Presentations PDF

UH Researchers Helping to Develop Opioid Disorder Vaccine Targeting Powerful Fentanyl Drug

Former Dean Mustafa Lokhandwala and Wife Establish College's First Professorship in Health Outcomes and Policy

2020 Headlines

2 Ph.D. Students Awarded AMCP Nexus Meeting Medals for Research

Ph.D. Students Earn AACR Scholar-in-Training Awards for Cancer Disparities Research

Aparasu Receives $450K NIA Grant to Study Dementia Drug Prescribing Cascade in Alzheimer's Disease Patients

UHCOP Welcomes Sang Kyu Cho to Pharmaceutical Health Outcomes and Policy Faculty

STEM Advocate, UH Alumnus and Former NASA Astronaut Harris Keynote Speaker at SPAC 2020

2019 Headlines

ISPOR 2019 Student & Faculty Presentations (.pdf)

4 PHOP Students Earn Travel Awards to Present at ISPOR 2019

Thornton, Premier Center Receives $3.34M Grant for Prescription Misuse Prevention

Medication Safety Symposium Highlights Deprescribing, Monitoring Programs

Aparasu Receives Fulbright Specialist Assignment to Indonesian University

Inside Outcomes Newsletter 2019 (.pdf)

2018 Headlines

Ph.D. Students Earn Internships in Pharmaceutical/Health Care Industry, Government

PHOP Graduate, Candidate Among 'Best Poster' Finalists at ISPOR

ISPOR Student & Faculty Presentations (.pdf)

Houston Medication Safety Symposium Program (.pdf)

Multidisciplinary Researchers, Practitioners Discuss Opioids, Medication Burden at Symposium

Alumnus Claims Top Abstract Medal, Podium Presentation Invite at AMCP Meeting

Inside Outcomes Newsletter 2018 (.pdf)

2017 Headlines

UHCOP Team Wins Historic Repeat Win in ISPOR Student Research Competition

PHOP Student, Faculty and Alumni Presentations at ISPOR 2017 Boston (.pdf)

Research Presentations Recognized at Houston Medication Safety Symposium

April 28 Houston Medication Safety Symposium Tackles Opioid Abuse, High Risk Drugs in Older Adults

Study of Prescription Drug Monitoring Program Suggests Abuse Going Underreported

Research Team Earns $207K Grant for Study of Anticoagulants, Antiarrhythmia Drugs in Afib

PHOP Alumna Ferries Wins Humana's Jim Bloem Award

2016 Headlines

PHOP Research on Parental Stress Among ISPOR European Congress Poster Finalists

Inside Outcomes PHOP Newsletter Summer 2016 (.pdf)

Sanofi Backs Fleming's Prescriber Webinar to Boost Statin Guidelines Adoption, Adherence

Regeneron Funds Abughosh Study on Motivational Interviewing, Statin Adherence

Graduate Students Land Internships in Pharmaceutical, Consulting Sectors

PHOP Team Takes Research Competition Trophy at ISPOR International Meeting

4 PHOP Projects Among ISPOR Research Posters Finalists

PHOP Presentations at ISPOR Interational Meeting 2016 (.pdf)

PHOP Doctoral Candidate Inducted into Phi Kappa Phi Honor Society

Project on COPD Patients in Medicare Gap Strikes Gold at AMCP Meeting

Aparasu Tapped for Fulbright Specialist Roster

(PDF links requires Adobe Reader; click here for free download.)